Detalhe da pesquisa
1.
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring.
Scand J Gastroenterol
; 58(8): 863-873, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799155
2.
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
Gastroenterology
; 160(5): 1784-1798.e0, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387530
3.
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort.
Scand J Gastroenterol
; 54(1): 41-48, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650312
4.
Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population.
Scand J Gastroenterol
; 53(6): 692-699, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29852793
5.
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Gut
; 66(4): 611-619, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26887816
6.
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study.
Crohns Colitis 360
; 6(1): otae013, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544907
7.
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.
Lancet Gastroenterol Hepatol
; 8(5): 458-492, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871566
8.
Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series.
Inflamm Bowel Dis
; 24(5): 997-1004, 2018 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668901
9.
Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
Inflamm Bowel Dis
; 23(10): 1752-1761, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28902124
10.
Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study.
Inflamm Bowel Dis
; 22(1): 141-5, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355464
11.
Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
J Crohns Colitis
; 6(3): 345-53, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22405172
12.
Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study.
Inflamm Bowel Dis
; 18(8): 1540-9, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21936030